Cost-Effectiveness Analysis of Tisagenlecleucel for the Treatment of Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma in the United States

2021 ◽  
Author(s):  
Cynthia Z. Qi ◽  
Vamsi Bollu ◽  
Hongbo Yang ◽  
Anand Dalal ◽  
Su Zhang ◽  
...  
Keyword(s):  
United States ◽  
Cost Effectiveness ◽  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
The United States ◽  
Cost Effectiveness Analysis ◽  
Large B Cell Lymphoma ◽  
Effectiveness Analysis ◽  
Large B Cell

scholarly journals Cost-Effectiveness Analysis of Rituximab Combined with CHOP for Treatment of Diffuse Large B-Cell Lymphoma

2005 ◽  
Vol 8 (4) ◽  
pp. 462-470 ◽  
Author(s):  
Jennie H. Best ◽  
John Hornberger ◽  
Stephen J. Proctor ◽  
Louis F. Omnes ◽  
Fred Jost
Keyword(s):  
Cost Effectiveness ◽  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Cost Effectiveness Analysis ◽  
Large B Cell Lymphoma ◽  
Effectiveness Analysis ◽  
Large B Cell

Cost-effectiveness of axicabtagene ciloleucel for adult patients with relapsed or refractory large B-cell lymphoma in the United States

2018 ◽  
Vol 21 (12) ◽  
pp. 1238-1245 ◽  
Author(s):  
Joshua A. Roth ◽  
Sean D. Sullivan ◽  
Vincent W. Lin ◽  
Aasthaa Bansal ◽  
Anna G. Purdum ◽  
...  
Keyword(s):  
United States ◽  
Cost Effectiveness ◽  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
The United States ◽  
Adult Patients ◽  
Large B Cell Lymphoma ◽  
Large B Cell
Sign in / Sign up

Export Citation Format

Share Document